ESOC 2021 | The need to improve secondary prevention approaches for stroke
Heinrich Audebert, MD, Charité, Center for Stroke Research Berlin, Berlin, Germany, gives an overview of existing secondary prevention approaches available to stroke patients, such as antihypertensives and cholesterol-lowering treatments. Prof. Audebert explains that despite the use of these prevention strategies, many patients still experience recurrent strokes. In other disease areas, support programs have shown to help patients adhere to their treatments and adapt to lifestyle changes. Therefore, implementing such programs may aid secondary stroke prevention and thus lower the risk of recurrent stroke events. This interview took place at the European Stroke Organisation Conference (ESOC), 2021.
Disclosures
Prof. Audebert reports the following disclosures:
I am the Principle Investigator of the INSPIRE-TMS and the B_PROUD studies, as well as the ULTRAFAST prehospital stroke diagnostics project. I have been member of the Flying Interventionalist Team study steering committee.
I have received honoraria for speaker and consultancy activities from Novo-Nordisk, Pfizer, MBS, Boehringer Ingelheim, Bayer Healthcare, and Medpoint. I have received institutional funding for the different areas of my research from the German Federal Ministry for Education and Research, the Deutsche Forschung Gemeinschaft, the German Innovation-Funds and the Stiftung Deutsche Schlaganfall-Hilfe.
